Extract

- safety of S 38093 as compared to placebo, - efficacy of S 38093 on cognitive performances, on neuropsychiatric symptoms and symptoms associated with dementia (including apathy and daytime sleepiness) and on the Clinical Global Impression of Change as compared to placebo, - S 38093 plasma concentrations which will be used for a population pharmacokinetic analysis

Inclusion criteria

• Alzheimer's disease

Links

• euctr
• ictrp
• euctr
• ictrp
• euctr
• ictrp